TNF and secondary progressive multiple sclerosis: To elucidate the contribution of inflammatory cytokines and MMP-2/9 to the BBB breakdown in patients with RRMS-R or SPMS, the TNF-α, IFN-γ, IL-17 or VEGF activities were neutralized using the corresponding neutralizing antibodies.